U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Figure 3.

Figure 3. From: Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up.

ORs and 95% CIs of each of the novel genetic association with SSc found in this study, in either the meta-analysis of all cohorts and each population separately.

Jose-Ezequiel Martin, et al. Hum Mol Genet. 2012 Jun 15;21(12):2825-2835.
2.
Figure 1.

Figure 1. From: Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up.

Schematic showing the overall process followed during the present study, along with the number of SNPs associated and considered in each step. lcSSc, limited cutaneous scleroderma; dcSSc, diffuse cutaneous scleroderma; ACA, anti-centromere autoantibody; ATA, anti-topoisomerase autoantibody.

Jose-Ezequiel Martin, et al. Hum Mol Genet. 2012 Jun 15;21(12):2825-2835.
3.
Figure 2.

Figure 2. From: Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up.

The Manhattan plot of the GWAS and replication cohorts meta-analysis. Grey dots represent P-values of SNPs which are genotyped only in the GWAS cohorts in the previous study by Radstake et al. (). Other color dots represent PMH values of the 720 SNPs which were in both the GWAS and the replication cohorts (Mantel–Haenszel meta-analysis). Gene names in black have been previously reported as genetic risk factors for SSc, while gene names in red are novel ones.

Jose-Ezequiel Martin, et al. Hum Mol Genet. 2012 Jun 15;21(12):2825-2835.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center